Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT, citing API sales and US market revenue decline. The company's ...

A record date is set by the company to determine which shareholders are eligible to receive the dividend. If your name is on ...

Mumbai: Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Many important names like Marico, Shree Cement, Aurobindo Pharma, Sona BLW Precision Forgings, Aditya Birla Capital, Sun ...

Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to Rs 824 crore for the June quarter ...

Aurobindo Pharma reports a 10% decline in consolidated net profit to Rs 824 crore for the June quarter, due to dwindling ...

Aurobindo Pharma Ltd. announced on Monday an interim dividend of Rs 4 per equity share with a face value of Re 1 for the ...

Aurobindo Pharma reports 10% decline in Q1 net profit to Rs 824 crore due to lower US sales. Revenue rises to Rs 7,868 crore.

Aurobindo Pharma Ltd. reported a 10.3 per cent year-on-year (YoY) decline in consolidated net profit to Rs 824.2 crore in Q1 ...

Aurobindo Pharma's revenue increased by 4% year-on-year for the three months ended June, reaching Rs 7,868 crore.

Aurobindo Pharma reported a 10.2% YoY decline in Q1 net profit to ₹824.2 crore, missing CNBC-TV18 estimates. Revenue rose 4%, ...

Indian drugmaker Aurobindo Pharma reported a lower first-quarter profit on Monday, as expenses grew faster than revenue - stung by weak prices in the key U.S. market.